New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
09:05 EDTALIMAlimera Sciences announces Scottish Medicines Consortium accepts Iluvien
Alimera Sciences announced that the Scottish Medicines Consortium, after completing its assessment and review of a simple patient access scheme, has accepted ILUVIEN for restricted use within the National Health Service Scotland. The advice issued by the SMC provides NHS Scotland patients considered insufficiently responsive to available therapies with access to ILUVIEN, the only sustained-release treatment for chronic diabetic macular edema.
News For ALIM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2015
07:37 EDTALIMAlimera Sciences signs exclusive agreement for distribution of Iluvien in Canada
Alimera Sciences announced that it has signed an exclusive agreement with Knight Therapeutics, a leading Canadian specialty pharmaceutical company, for the distribution in Canada of ILUVIEN, Alimera's sustained release intravitreal implant for the treatment of diabetic macular edema. Under the terms of this agreement, Knight will also handle all regulatory and commercial activities for ILUVIEN in Canada. ILUVIEN currently is not approved for sale in Canada.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use